4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000950170-24-042381
Chief Financial Officer sold 15,630 shares at $6.17 ($96,421)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moran Kyle · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-03 | Sale : show line 1 in the form 10b5-1 | −15,630 | $6.17 | $96,421 | 33,921 | D |
| Open-market sales · 15,630 sh · avg $6.17 · $96,421 | ||||||
Loading xslF345X05/ownership.xml…